Bone Biology and Anabolic Therapies for Bone: Current Status and Future Prospects
T. John Martin
J Bone Metab. 2014;21(1):8-20.   Published online 2014 Feb 28     DOI: https://doi.org/10.11005/jbm.2014.21.1.8
Citations to this article as recorded by Crossref logo
Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives
Chenggui Zhang, Chunli Song
Frontiers in Pharmacology.2021;[Epub]     CrossRef
Experimental and molecular docking studies of estrogen-like and anti-osteoporosis activity of compounds in Fructus Psoraleae
Xin-yin Cai, Zi-jia Zhang, Jing-lin Xiong, Meng Yang, Zheng-tao Wang
Journal of Ethnopharmacology.2021; 276: 114044.     CrossRef
Unique anabolic action of stem cell gene therapy overexpressing PDGFB-DSS6 fusion protein in OVX osteoporosis mouse model
Wanqiu Chen, Samiksha Wasnik, Yawen Fu, Leslie Aranda, Charles H. Rundle, Kin-Hing William Lau, David J. Baylink, Xiaobing Zhang
Bone Reports.2020; 12: 100236.     CrossRef
IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95
Hyunsoo Kim, Noriko Takegahara, Matthew C. Walsh, Sarah A. Middleton, Jiyeon Yu, Jumpei Shirakawa, Jun Ueda, Yoshitaka Fujihara, Masahito Ikawa, Masaru Ishii, Junhyong Kim, Yongwon Choi
Bone Research.2020;[Epub]     CrossRef
GDNF secreted by pre-osteoclasts induces migration of bone marrow mesenchymal stem cells and stimulates osteogenesis
Sol Yi, Jihee Kim, Soo Young Lee
BMB Reports.2020; 53(12): 646.     CrossRef
RACK1 interaction with c-Src is essential for osteoclast function
Jin Hee Park, Eutteum Jeong, Jingjing Lin, Ryeojin Ko, Ji Hee Kim, Sol Yi, Youngjin Choi, In-Cheol Kang, Daekee Lee, Soo Young Lee
Experimental & Molecular Medicine.2019; 51(7): 1.     CrossRef
MicroRNA‐130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate
Zhangyuan Lin, Hongbo He, Min Wang, Jieyu Liang
Cell Proliferation.2019;[Epub]     CrossRef
Antiresorptive and anabolic agents in the prevention and reversal of bone fragility
Ego Seeman, T. J. Martin
Nature Reviews Rheumatology.2019; 15(4): 225.     CrossRef
Effects of bone remodeling agents following teriparatide treatment
D. Burkard, T. Beckett, E. Kourtjian, C. Messingschlager, R. Sipahi, M. Padley, J. Stubbart
Osteoporosis International.2018; 29(6): 1351.     CrossRef
Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis
Changki Lee, Young Mi Whang, Preston Campbell, Patrick L. Mulcrone, Florent Elefteriou, Sun Wook Cho, Serk In Park
Cancer Letters.2018; 414: 205.     CrossRef
Discovery of a tetrazolyl β-carboline with in vitro and in vivo osteoprotective activity under estrogen-deficient conditions
Anirudha Karvande, Shahnawaz Khan, Irfan Khan, Deepti Singh, Vikram Khedgikar, Priyanka Kushwaha, Naseer Ahmad, Priyanka Kothari, Anupam Dhasmana, Ruchir Kant, Ritu Trivedi, Prem M. S. Chauhan
MedChemComm.2018; 9(7): 1213.     CrossRef
Differentially Expressed MicroRNAs in Conservatively Treated Nontraumatic Osteonecrosis Compared with Healthy Controls
Biaofang Wei, Wei Wei, Liang Wang, Baoxiang Zhao
BioMed Research International.2018; 2018: 1.     CrossRef
Comparative Characterization of Osteoclasts Derived From Murine Bone Marrow Macrophages and RAW 264.7 Cells Using Quantitative Proteomics
Andrew YH Ng, Chengjian Tu, Shichen Shen, Ding Xu, Merry J Oursler, Jun Qu, Shuying Yang
JBMR Plus.2018; 2(6): 328.     CrossRef
Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
Benjamin Z Leder
JBMR Plus.2018; 2(2): 62.     CrossRef
NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells
Won Jong Jin, Bongjun Kim, Darong Kim, Hea-Young Park Choo, Hong-Hee Kim, Hyunil Ha, Zang Hee Lee
Experimental & Molecular Medicine.2017; 49(2): e295.     CrossRef
Small non-coding RNAs-based bone regulation and targeting therapeutic strategies
Ying Yang, Sijie Fang
Molecular and Cellular Endocrinology.2017; 456: 16.     CrossRef
Unexpected Bone Formation Produced by RANKL Blockade
Sergio Portal-Núñez, Aranzazu Mediero, Pedro Esbrit, Olga Sánchez-Pernaute, Raquel Largo, Gabriel Herrero-Beaumont
Trends in Endocrinology & Metabolism.2017; 28(10): 695.     CrossRef
Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment
Jun Guo, Ashok Khatri, Akira Maeda, John T Potts, Harald Jüppner, Thomas J Gardella
Journal of Bone and Mineral Research.2017; 32(1): 86.     CrossRef
Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy
Benjamin Z. Leder
Current Osteoporosis Reports.2017; 15(2): 110.     CrossRef
The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products
Muberra Namlı Kalem, Ziya Kalem, Nilufer Akgun, Batuhan Bakırarar
Archives of Gynecology and Obstetrics.2017; 295(3): 785.     CrossRef
Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up)
Benjamin Z. Leder, Joy N. Tsai, Linda A. Jiang, Hang Lee
Bone.2017; 98: 54.     CrossRef
The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts
Hyunsoo Kim, Matthew C. Walsh, Noriko Takegahara, Sarah A. Middleton, Hong-In Shin, Junhyong Kim, Yongwon Choi
Scientific Reports.2017;[Epub]     CrossRef
Sepsis-Induced Osteoblast Ablation Causes Immunodeficiency
Asuka Terashima, Kazuo Okamoto, Tomoki Nakashima, Shizuo Akira, Koichi Ikuta, Hiroshi Takayanagi
Immunity.2016; 44(6): 1434.     CrossRef
Molecular mechanisms of osteoporotic hip fractures in elderly women
Ursula Föger-Samwald, György Vekszler, Edith Hörz-Schuch, Sylvia Salem, Markus Wipperich, Peter Ritschl, Mehdi Mousavi, Peter Pietschmann
Experimental Gerontology.2016; 73: 49.     CrossRef
Local and targeted drug delivery for bone regeneration
Maureen R Newman, Danielle SW Benoit
Current Opinion in Biotechnology.2016; 40: 125.     CrossRef
Sclerostin expression in skeletal sarcomas
Jia Shen, Carolyn A. Meyers, Swati Shrestha, Arun Singh, Greg LaChaud, Vi Nguyen, Greg Asatrian, Noah Federman, Nicholas Bernthal, Fritz C. Eilber, Sarah M. Dry, Kang Ting, Chia Soo, Aaron W. James
Human Pathology.2016; 58: 24.     CrossRef
Small molecule inhibitors of the Dishevelled‐ CXXC 5 interaction are new drug candidates for bone anabolic osteoporosis therapy
Hyun‐Yi Kim, Sehee Choi, Ji‐Hye Yoon, Hwan Jung Lim, Hyuk Lee, Jiwon Choi, Eun Ji Ro, Jung‐Nyoung Heo, Weontae Lee, Kyoung Tai No, Kang‐Yell Choi
EMBO Molecular Medicine.2016; 8(4): 375.     CrossRef
Anabolic effects of PTH and the ‘anabolic window’
Michael Pazianas
Trends in Endocrinology & Metabolism.2015; 26(3): 111.     CrossRef
The Role and Regulation of Osteoclasts in Normal Bone Homeostasis and in Response to Injury
Adrian McArdle, Owen Marecic, Ruth Tevlin, Graham G. Walmsley, Charles K. F. Chan, Michael T. Longaker, Derrick C. Wan
Plastic and Reconstructive Surgery.2015; 135(3): 808.     CrossRef
Identification of aberrantly expressed of serum microRNAs in patients with hormone-induced non-traumatic osteonecrosis of the femoral head
Biaofang Wei, Wei Wei
Biomedicine & Pharmacotherapy.2015; 75: 191.     CrossRef
β₂Adrenergic Receptor Activation Suppresses Bone Morphogenetic Protein (BMP)‐Induced Alkaline Phosphatase Expression in Osteoblast‐Like MC3T3E1 Cells
Takayuki Yamada, Yoichi Ezura, Tadayoshi Hayata, Shuichi Moriya, Jumpei Shirakawa, Takuya Notomi, Smriti Arayal, Makiri Kawasaki, Yayoi Izu, Kiyoshi Harada, Masaki Noda
Journal of Cellular Biochemistry.2015; 116(6): 1144.     CrossRef
Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs)
Perrine J Martin, Nathalie Haren, Olfa Ghali, Aline Clabaut, Christophe Chauveau, Pierre Hardouin, Odile Broux
BMC Cell Biology.2015;[Epub]     CrossRef
Dynamic interplay between bone and multiple myeloma: Emerging roles of the osteoblast
Michaela R. Reagan, Lucy Liaw, Clifford J. Rosen, Irene M. Ghobrial
Bone.2015; 75: 161.     CrossRef
MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation
Chang-Jun Li, Peng Cheng, Meng-Ke Liang, Yu-Si Chen, Qiong Lu, Jin-Yu Wang, Zhu-Ying Xia, Hou-De Zhou, Xu Cao, Hui Xie, Er-Yuan Liao, Xiang-Hang Luo
Journal of Clinical Investigation.2015; 125(4): 1509.     CrossRef
Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies
Pierre J. Marie
Cellular and Molecular Life Sciences.2015; 72(7): 1347.     CrossRef
The Effect of Discontinuing Treatment With Blosozumab: Follow‐up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density
Christopher P Recknor, Robert R Recker, Charles T Benson, Deborah A Robins, Alan Y Chiang, Jahangir Alam, Leijun Hu, Toshio Matsumoto, Hideaki Sowa, John H Sloan, Robert J Konrad, Bruce H Mitlak, Adrien A Sipos
Journal of Bone and Mineral Research.2015; 30(9): 1717.     CrossRef
LL-37 Peptide Enhancement of Signal Transduction by Toll-like Receptor 3 Is Regulated by pH
Divyendu Singh, Robert Vaughan, C. Cheng Kao
Journal of Biological Chemistry.2014; 289(40): 27614.     CrossRef
Osteoporosis
Mark S. Nanes, Caleb B. Kallen
Seminars in Nuclear Medicine.2014; 44(6): 439.     CrossRef
A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts
Hyun-Ju Kim, Hye-Jin Yoon, Shin-Yoon Kim, Young-Ran Yoon
Molecules and Cells.2014; 37(8): 598.     CrossRef
Integrin and cadherin signaling in bone: role and potential therapeutic targets
Pierre J. Marie, Eric Haÿ, Zuzana Saidak
Trends in Endocrinology & Metabolism.2014; 25(11): 567.     CrossRef